Yoshinori Abe

9PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 17, 2024
PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.

Yoshinori Abe, Takumi Sano, Naoki Otsuka

|Mar 29, 2023
The Role of PRMT5 in Immuno-Oncology.

Yoshinori Abe, Takumi Sano, Nobuyuki Tanaka

|Dec 23, 2022
Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model.

Yusuke Motoji, Ryuji Fukazawa, Ryosuke Matsui

|Feb 26, 2020
MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients.

Wataru Sugimoto, Katsuhiko Itoh, Hiroaki Hirata

Pageof 2